Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chase Dean

Adult Reconstructive Orthopaedic Surgery Tucker, GA Medical Doctor

NPI 1386007201 CMS profile 5700140

1455 Montreal Rd, Tucker, GA 30084

Open in the dashboard

General payments

$44,481

148 records reported · program years 2019–2025

Research payments

$1,500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Chase Dean of Tucker, GA is reported in the CMS Open Payments database as having received $44,481 across 148 general payments and $1,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,561 38
2025 Research $1,500 1
2024 General $4,433 22
2023 General $1,800 18
2022 General $15,971 54
2021 General $8,681 15
2019 General $1,035 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chase Dean
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Chase Dean were reported at $12,561. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Chase Dean Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $1,035 $1,416 $292–$9,336 $163
2020 $0 $647 $141–$6,474 $114
2021 $8,681 $1,073 $211–$6,497 $132
2022 $15,971 $1,217 $236–$6,299 $149
2023 $1,800 $1,082 $246–$6,818 $160
2024 $4,433 $1,575 $323–$8,944 $164
2025 $12,561 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $27,107 87 payments
  2. Bone Support Inc. $9,403 12 payments
  3. Zimmer Biomet Holdings, Inc. $3,397 10 payments
  4. Gemini Mountain Medical, LLC $1,035 1 payment
  5. Stryker Corporation $783 9 payments
  6. Think Surgical, Inc. $398 2 payments
  7. Medacta USA, Inc. $384 3 payments
  8. MicroPort Orthopedics Inc $357 2 payments
  9. DePuy Synthes Sales Inc. $284 4 payments
  10. Osteoremedies, LLC $217 1 payment
  11. Other $1,117 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $16,226 4 payments
  2. Food and Beverage $11,000 121 payments
  3. Consulting Fee $8,000 5 payments
  4. Travel and Lodging $6,797 16 payments
  5. Long term medical supply or device loan $2,459 2 payments
Products named General payments · program years 2019–2025
  1. CERAMENTBONE VOID FILLER $9,403 12 payments
  2. CERAMENT G $9,403 12 payments
  3. REAL INTELLIGENCE $7,522 45 payments
  4. REDAPT $5,431 30 payments
  5. LEGION Revision $5,404 24 payments
  6. JOURNEY II Recon Knees $4,751 20 payments
  7. JOURNEY $1,826 9 payments
  8. TANDEM $1,671 5 payments
  9. OR3O Dual Mobility $1,538 8 payments
  10. JOURNEY II Recon Knees $914 3 payments
  11. Other $8,742 85 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Bone Suppport AB $1,500 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

353

Median for Orthopedic Surgery: 203

Drug cost

$939

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 96 $342
Pregabalin Generic 42 $220
Amoxicillin Generic 127 $128
Methylprednisolone Generic 27 $124
Clindamycin Hcl Generic 33 $64
Meloxicam Generic 15 $45
Tramadol Hcl Generic 13 $17

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$146,556

Of which drugs: $1,461

Medicare patients

194

Average age 76

Services billed

5,124

114 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 30%
Depression 29%
Diabetes 25%
Chronic kidney disease 23%
Cancer 21%
Atrial fibrillation 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 39 4,085 $414
Injection, methylprednisolone acetate, 80 mg J1040 Office 13 16 $87

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

149 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record